References
- Broze G J, Majerus P W. Purification and properties of human coagulation factor VII. J Biol Chem 1980; 255: 1242–7
- Bauer K A, Kass B L, Ten Cate H, Hawiger J J, Rosenberg R D. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731–6
- Marliar R A, Kleiss A J, Griffin J H. An alternative extrinsic pathway of human blood coagulation. Blood 1982; 60: 1353–8
- Zur M, Radcliffe R D, Oberdick J, Nemerson Y. The dual role of factor VII in blood coagulation. J Biol Chem 1982; 257: 5623–31
- Rao L VM, Rapaport S I, Bajaj S P. Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood 1986; 68: 685–91
- Rao L VM, Rapaport S I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl AcadSci 1988; 85: 6687–91
- Yamamoto M, Nakagaki T, Kisiel W. Tissue-factor dependent autoactivation of human blood coagulation factor VII. J Biol Chem 1992; 267: 19089–94
- Mann K G, Lawson J H. The role of the membrane in the expression of the vitamin K-dependent enzymes. Arch Pathol Lab Med 1992; 116: 1330–6
- Bajaj S P, Rapaport S I, Brown S F. Isolation and characterization of human factor VII. J Biol Chem 1981; 256: 253–9
- Bladbjerg E M, Marckmann P, Sandstrom B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755–8
- Poller Thomson L. J. The Manchester comparative reagent. A national reference standard for anticoagulant therapy. Human blood coagulation, H C Hemker, E A Loeliger, J J Velt-Kamp. Leiden University Press. 1969; 290–5, Chapter III: Laboratory methods
- Lindahl A K, Sandset P M, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinol 1992; 3: 439–49
- Wilson P W, Garisson R J, Castelli W P, Feinleib M, McNamara P M, Kannel W B. Prevalence of coronary heart disease in the Framingham offspring study: Role of lipoprotein cholesterols. Am J Cardiol 1980; 46: 649–54
- Morrissey J H, Macik B G, Neuenschwander P F, Comp P H. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734–44
- Seligsohn U, Osterud B, Brown S F, Griffin J H, Rapaport S I. Activation of human factor VII in plasma and purified systems. J Clin Invest 1979; 64: 1056–65
- Muller A D, Van Deijk W A, Devilee P P, Van Dam-Mieras M CE, Hemker H C. The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII. Br J Haematol 1986; 62: 367–77
- Mitropoulos K A, Martin J C, Burgess A I, Esnouf M P, Stirling Y, Howarth D J, Reeves B EA. The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII. Thromb Haemost 1990; 63: 349–55
- Rao L VM, Rapaport S I, Hoang A D. Binding of factor Vila to tissue factor permits rapid anti-thrombin Hl/heparin inhibition of factor Vila. Blood 1993; 81: 2600–7
- Broze G J, Likert K, Higuchi D. Inhibition of factor Vila/tissue factor by antithrombin III and tissue factor pathway inhibitor. Blood 1993; 82: 1679–80, letter